SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples 
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand 
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race 
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions 
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions 
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures 
Carro Expands Into Australia With Acquisition of Used-Car Platform CarPlace 
JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics 
BHP Shares Fall as Jansen Potash Project Costs Surge 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation 
SAN CLEMENTE, Calif., Jan. 22, 2016 -- ICU Medical, Inc., (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced the time of its fourth quarter and fiscal year 2015 earnings release conference call.
The Company will release its fourth quarter and full year 2015 results at approximately 4:00 p.m. EST (1:00 p.m. PST) and will be conducting a conference call concerning those results at 4:30 p.m. EST (1:30 p.m. PST) on Wednesday, February 3, 2016. The call can be accessed at (800) 936-9761, international (408) 774-4587, conference ID 34390619. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical, Inc.
ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical technologies used in infusion therapy, oncology, and critical care applications. ICU Medical's products improve patient outcomes by helping prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. The Company's complete product line includes custom IV systems, closed delivery systems for hazardous drugs, needlefree IV connectors, closed blood sampling systems, and hemodynamic monitoring systems. ICU Medical is headquartered in San Clemente, California. For more information, visit the Company's website at www.icumed.com.
CONTACT: ICU Medical, Inc. Scott Lamb, Chief Financial Officer (949) 366-2183 ICR, Inc. John Mills, Partner (646) 277-1254
